oxybutynin chloride tablet film coated extended release
1 INDICATIONS AND USAGE Oxybutynin chloride extended - release tablets are muscarinic antagonist indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and frequency. Oxybutynin chloride extended - release tablets are also indicated for the treatment of pediatric patients aged 6 years and older with symptoms of detrusor overactivity associated with a neurological condition (e.g., spina bifida). Oxybutynin chloride extended - release tablets are muscarinic antagonist indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and frequency. (1) Oxybutynin chloride extended - release tablets are also indicated for the treatment of pediatric patients aged 6 years and older with symptoms of detrusor overactivity associated with a neurological condition (e.g., spina bifida). (1)
bionpharma inc.
Related Pills
valsartan tablet film coated
ohm laboratories inc.
eluxadoline 100 MG Oral Tablet Viberzi
ALLERGAN USA, INC.
24 HR Minocycline 80 MG Extended Release Oral Tablet
Mylan Pharmaceuticals Inc.
24 HR Minocycline 105 MG Extended Release Oral Tablet
Mylan Pharmaceuticals Inc.
alosetron 0.5 MG Oral Tablet
Actavis Pharma, Inc.
DISCLAIMER:
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site
16 HOW SUPPLIED/STORAGE AND HANDLING
OXYBUTYNIN CHLORIDE extended-release tablets, USP are available in three dosage strengths, 5 mg (white), 10 mg (white), and 15 mg (white) and are round, biconvex, film-coated tablets, debossed with “X1”, “X2”, or “X3” and plain on the other side.
OXYBUTYNIN CHLORIDE extended-release tablets, USP are supplied in bottles of 100‑tablets. 5 mg 100 count bottle NDC 69452-119-20 10 mg 100 count bottle NDC 69452-120-20 15 mg 100 count bottle NDC 69452-121-20 Storage Store at 25°C (77°F); excursions permitted to 15° to 30°C (59° to 86°F) [See USP Controlled Room Temperature]. Protect from moisture and humidity. Keep out of reach of children.
More pills like ROUND X1